肝血管平滑肌脂肪瘤:定量超声造影灌注分析与磁共振成像的临床特征及影像表现
回顾性分析26个病理证实的肝血管平滑肌脂肪瘤(AML)CEUS病灶与60例确诊肝细胞癌(HCC)患者,比较临床、超声及定量CEUS参数和MRI表现。定量CEUS参数鉴别AML与HCC的敏感度61.5%~96.2%、特异度55.0%~71.7%,CEUS与MRI阳性预测值无显著差异(P>.05);上皮型AML与非上皮型AML的定量参数敏感度68.7%~100.0%、特异度60.0%~100.0%,CEUS与MRI阳性预测值有显著差异(P<.05)。结论认为定量CEUS表现可能有助于鉴别EAML与HCC。
要点
- AML较HCC更常见单发肿瘤(P<.001)、边界清晰(P=.025)和高回声(P<.001)。
- 向心性充填、CEUS延迟期低增强较轻、高PI和上升斜率、短FT和MTT有助于鉴别肿瘤类型(P<.05)。
- MRI早期引流静脉和肿瘤血管、瘤内脂肪、无假包膜、DWI轻度高信号、延迟期低信号有助于鉴别AML与HCC(P<.05)。
核心结论
- 定量CEUS表现可能有助于鉴别上皮型AML与HCC。
- 定量CEUS参数鉴别AML与HCC的敏感度61.5%~96.2%、特异度55.0%~71.7%(AUC 0.642~0.773)。
- 定量CEUS参数鉴别上皮型AML与非上皮型AML的敏感度68.7%~100.0%、特异度60.0%~100.0%(AUC 0.825~0.941)。
研究设计与样本
- 回顾性分析26个病理证实的AML CEUS病灶与60例确诊HCC患者。
- 分析AML与HCC、上皮型AML与非上皮型AML的临床和超声特征。
- 定量参数包括到达时间、上升斜率、达峰时间、峰值强度(PI)、下降时间(FT)和平均通过时间(MTT)。
- 比较MRI与CEUS的诊断效能。
关键影像表现/征象
- AML与HCC的超声表现差异有统计学意义:单发肿瘤(P<.001)、边界清晰(P=.025)、高回声(P<.001)。
- 肿瘤类型间超声表现差异有统计学意义:向心性充填模式(P<.001)、CEUS延迟期低增强较轻(P=.04)、高PI(P=.007)和上升斜率(P=.006)、短FT(P=.001)和MTT(P<.05)。
- MRI上早期引流静脉和肿瘤血管、瘤内脂肪、无假包膜、DWI轻度信号强度、延迟期低信号有助于鉴别AML与HCC(P<.05)。
- 上皮型AML较非上皮型AML更可能表现为低回声伴向心性充填模式(P<.05)。
- 上皮型AML的MTT和FT短于非上皮型AML(P<.05),PI显著强于非上皮型AML(P<.01)。
诊断标准与关键数值
- 定量CEUS参数鉴别AML与HCC的敏感度61.5%~96.2%、特异度55.0%~71.7%(AUC 0.642~0.773)。
- 定量CEUS参数鉴别上皮型AML与非上皮型AML的敏感度68.7%~100.0%、特异度60.0%~100.0%(AUC 0.825~0.941)。
- CEUS与MRI鉴别AML与HCC的阳性预测值分别为46.3%~100%和42.9%~75%,无显著差异(P>.05)。
- CEUS与MRI鉴别上皮型AML与非上皮型AML的阳性预测值分别为77.8%~100%和85.7%,有显著差异(P<.05)。
临床应用与阅片要点
- 定量CEUS参数(到达时间、上升斜率、达峰时间、PI、FT、MTT)可用于AML与HCC的鉴别分析。
- MRI征象(早期引流静脉和肿瘤血管、瘤内脂肪、无假包膜、DWI轻度信号强度、延迟期低信号)有助于AML与HCC的鉴别。
- 上皮型AML与非上皮型AML的超声表现和定量CEUS参数存在差异,可辅助分型鉴别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate whether quantitative contrast-enhanced ultrasound (CEUS) analysis and magnetic resonance imaging (MRI) can differentiate hepatic angiomyolipoma (AML) from hepatocellular carcinoma (HCC) and hepatic epithelial angiomyolipoma (EAML) from nonepithelial AML.
METHODS: Retrospective analysis of 26 CEUS lesions pathologically confirmed as AML and 60 patients with confirmed HCC. Clinical and ultrasound (US) features of AML versus HCC and EAML versus nonepithelial AML were analyzed. Quantitative parameters, including arrival time, ascending slope, time to peak, peak intensity (PI), fall time (FT), and mean transit time (MTT), were analyzed. Diagnostic performance of MRI and CEUS was compared.
RESULTS: Angiomyolipoma was significantly different from HCC in US findings of solitary tumor (P < .001), well-defined border (P = .025), and hyperechogenicity (P < .001). Tumor types were significantly different in US findings of centripetal filling pattern (P < .001), less hypoenhancement in the CEUS delayed phase (P = .04), high PI (P = .007) and ascending slope (P = .006), and short FT (P = .001) and MTT (P < .05). The sensitivity and specificity of quantitative parameters were 61.5% to 96.2% and 55.0% to 71.7% (area under the curve, 0.642-0.773). An early draining vein and tumor vessels, intratumor fat, absence of pseudocapsules, mild signal intensity on diffusion-weighted imaging, and hypointensity in the MRI delayed phase were helpful for differentiation of AML from HCC (P < .05). The positive predictive values of CEUS and MRI were 46.3% to 100% and 42.9% to 75%, with no significant difference (P > .05). Epithelial AML was more likely to be hypoechoic with a centripetal filling pattern than nonepithelial AML (P < .05). The MTT and FT of EAML were shorter than those of nonepithelial AML (P < .05). The PI of EAML was significantly stronger than that of nonepithelial AML (P < .01). The sensitivity and specificity of quantitative parameters were 68.7% to 100.0% and 60.0% to 100.0% (area under the curve, 0.825-0.941). Less intratumor fat was helpful for differentiation of EAML from nonepithelial AML (P < .05). The positive predictive values of CEUS and MRI were 77.8% to 100% and 85.7%, with a significant difference (P < .05).
CONCLUSIONS: Quantitative CEUS findings could be valuable in differentiating EAML from HCC.
引用
- Huang Z, Zhou P, Li S, et al. Hepatic Angiomyolipoma: Clinical Features and Imaging Findings of Quantitative Contrast-Enhanced Ultrasound Perfusion Analysis and Magnetic Resonance Imaging. J Ultrasound Med. 2020. PMID: 32383807. doi:10.1002/jum.15316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。